Literature DB >> 16131804

Novel magnetic resonance angiography stage grading for moyamoya disease.

Kiyohiro Houkin1, Naoki Nakayama, Satoshi Kuroda, Tadashi Nonaka, Takaharu Shonai, Takashi Yoshimoto.   

Abstract

BACKGROUND: Magnetic resonance angiography (MRA) has been acknowledged as a noninvasive diagnostic modality for moyamoya disease. However, in terms of staging of moyamoya disease, conventional angiography is still the gold standard. Therefore, the purpose of this study was to establish MRA grades for moyamoya disease as an alternative to conventional angiography.
METHODS: Twenty-two patients (44 sides) with moyamoya disease diagnosed by conventional angiography were evaluated by MRA during the past 5 years. MRA scores were assigned based on the severity of occlusive changes of the internal carotid artery, the horizontal portion of the middle cerebral artery, the anterior and the posterior cerebral arteries and the signals of the distal branches of these arteries. Total points ranged from 0 (normal) to 10 (most severe).
RESULTS: MRA scores (0-10) were significantly consistent with the conventional angiographic staging. Four grades based on this novel MRA scores correlated well with Suzuki's stages, with high sensitivity and specificity.
CONCLUSIONS: These novel MRA grades can be a reliable alternative to conventional staging. By employing these novel MRA grades, the use of conventional angiography can be avoided for the purpose of evaluation of the stages of moyamoya disease. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16131804     DOI: 10.1159/000087935

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  24 in total

1.  Predictive factors for acute thrombogenesis occurring immediately after bypass procedure for moyamoya disease.

Authors:  Takeshi Mikami; Hime Suzuki; Ryo Ukai; Katsuya Komatsu; Yukinori Akiyama; Masahiko Wanibuchi; Kiyohiro Houkin; Nobuhiro Mikuni
Journal:  Neurosurg Rev       Date:  2019-02-14       Impact factor: 3.042

2.  Assessment of the cortical artery using computed tomography angiography for bypass surgery in moyamoya disease.

Authors:  Hime Suzuki; Takeshi Mikami; Katsuya Komatsu; Shouhei Noshiro; Kei Miyata; Toru Hirano; Masahiko Wanibuchi; Nobuhiro Mikuni
Journal:  Neurosurg Rev       Date:  2016-07-30       Impact factor: 3.042

3.  Diagnosis of moyamoya disease using 3-T MRI and MRA: value of cisternal moyamoya vessels.

Authors:  Takeshi Sawada; Akira Yamamoto; Yukio Miki; Ken-Ichiro Kikuta; Tomohisa Okada; Mitsunori Kanagaki; Seiko Kasahara; Susumu Miyamoto; Jun C Takahashi; Hidenao Fukuyama; Kaori Togashi
Journal:  Neuroradiology       Date:  2012-02-21       Impact factor: 2.804

4.  Changes in integrity of normal-appearing white matter in patients with moyamoya disease: a diffusion tensor imaging study.

Authors:  H Jeong; J Kim; H S Choi; E S Kim; D-S Kim; K-W Shim; S-K Lee
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

5.  Age-specific eNOS polymorphisms in moyamoya disease.

Authors:  Young Seok Park; Kyung Tae Min; Tae-Gon Kim; Yun Ho Lee; Hee Jin Cheong; In Sun Yeom; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  Childs Nerv Syst       Date:  2011-06-21       Impact factor: 1.475

6.  Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with 15O-Gas PET and DSC-MRI.

Authors:  S Hara; Y Tanaka; Y Ueda; S Hayashi; M Inaji; K Ishiwata; K Ishii; T Maehara; T Nariai
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-16       Impact factor: 3.825

7.  Unilateral hemispheric proliferation of ivy sign on fluid-attenuated inversion recovery images in moyamoya disease correlates highly with ipsilateral hemispheric decrease of cerebrovascular reserve.

Authors:  M Kawashima; T Noguchi; Y Takase; T Ootsuka; N Kido; T Matsushima
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-27       Impact factor: 3.825

8.  Predictive validity of severity grading for cerebral steno-occlusive arteriopathy in recurrent childhood ischemic stroke.

Authors:  Sally M Sultan; Lauren A Beslow; Arastoo Vossough; Mitchell S V Elkind; Scott E Kasner; David M Mirsky; Daniel J Licht; Rebecca N Ichord
Journal:  Int J Stroke       Date:  2014-08-08       Impact factor: 5.266

9.  Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease.

Authors:  Jai-Hyuck Han; Young Seok Park; Won Hyoung Lee; Sung-Soo Koong; Kyung-Soo Min; Mou-Seop Lee; Young-Gyu Kim; Dong-Ho Kim; Kyung-Sil Yi; Sang-Hoon Cha
Journal:  Childs Nerv Syst       Date:  2015-12-11       Impact factor: 1.475

10.  Cerebrovascular Reactivity Mapping Using Resting-State BOLD Functional MRI in Healthy Adults and Patients with Moyamoya Disease.

Authors:  Peiying Liu; Gongkai Liu; Marco C Pinho; Zixuan Lin; Binu P Thomas; Melissa Rundle; Denise C Park; Judy Huang; Babu G Welch; Hanzhang Lu
Journal:  Radiology       Date:  2021-03-09       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.